Humana HUM Stock Sinks, Driving Down Insurers, After Cutting Medicare Outlook
Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. As of March 15th, there was short interest totaling 1,850,000 shares, a decrease of 8.4% from the February 28th total of 2,020,000 shares.
This is a boost from the what is principal’s liability‘s previous quarterly dividend of $0.79. According to analysts’ consensus price target of $594.12, Humana has a forecasted upside of 14.3% from its current price of $519.97. HUM’s stock has risen by 0.64% in the past week, with a monthly rise of 2.01% and a quarterly drop of -0.38%. The volatility ratio for the week is 2.97% while the volatility levels for the last 30 days are 2.49% for Humana Inc. The simple moving average for the last 20 days is 3.86% for HUM stock, with a simple moving average of 2.21% for the last 200 days. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company.
Data may be intentionally delayed pursuant to supplier requirements. Measures how much net income or profit is generated as a percentage of revenue.
The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank.
JNJ: 3 Stocks That Could Deliver Healthy Returns This Year – StockNews.com
JNJ: 3 Stocks That Could Deliver Healthy Returns This Year.
Posted: Fri, 17 Mar 2023 07:00:00 GMT [source]
By https://1investing.in/.com Staff Managed care stocks are lower Thursday after Medicare Advantage proposed a rate decrease of 2.27% for 2024. This is below the 1-2% increase Oppenheimer analysts were… Insiders have sold a total of 151,533 Humana shares in the last 24 months for a total of $73,977,260.70 sold.
Stock Price Prediction, Stock Forecast for next months and years
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Humana reported nearly $700 million in profits in the second quarter thanks to lower than expected medical and administrative costs.
2 Great Value Stocks to Buy in April and Hold for Years – Yahoo Finance
2 Great Value Stocks to Buy in April and Hold for Years.
Posted: Fri, 31 Mar 2023 20:28:08 GMT [source]
The business also recently declared a quarterly dividend, which will be paid on Friday, April 28th. Stockholders of record on Friday, March 31st will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend is Thursday, March 30th.
These returns cover a period from January 1, 1988 through February 6, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.
Deutsche Bank Aktiengesellschaft cut their target price on shares of Humana from $575.00 to $562.00 and set a “buy” rating on the stock in a report on Tuesday, February 28th. Cowen decreased their target price on shares of Humana from $647.00 to $581.00 and set an “outperform” rating on the stock in a report on Monday, February 6th. UBS Group decreased their target price on Humana from $645.00 to $620.00 and set a “buy” rating for the company in a research note on Thursday, February 2nd. Credit Suisse Group reduced their target price on shares of Humana from $635.00 to $575.00 and set an “outperform” rating for the company in a research note on Monday, February 6th. Finally, Truist Financial reduced their price objective on Humana from $580.00 to $560.00 and set a “hold” rating for the company in a report on Tuesday, February 7th. Two equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock.
Market cap or market capitalization is the total market value of all of a company’s outstanding shares. Fusion Mediawould like to remind you that the data contained in this website is not necessarily real-time nor accurate. The Company offers coordinated health insurance coverage and related services through a variety of traditional and consumer-choice plans for government-sponsored programs, employer groups, and individuals. Market Voice allows investors to share their opinions on stocks. Then compare your rating with others and see how opinions have changed over the week, month or longer.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
Only 10 people have added Humana to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days. Only 41 people have searched for HUM on MarketBeat in the last 30 days. This is a decrease of -7% compared to the previous 30 days. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. Upgrade to MarketBeat All Access to add more stocks to your watchlist.
Humana Inc. engages in the provision of health insurance services. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr. , and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY. Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price.
This is a positive change from Humana’s previous quarterly dividend of $0.79. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.68%. Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market.
- New York, Oct 4 Automation Anywhere, a leader in cloud-native intelligent automation, on Tuesday unveiled the Automation Success Platform which is designed to accelerate business…
- This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system.
- After a stumble in the market that brought HUM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.69% of loss for the given period.
- Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
- Bruce D. Broussard has an approval rating of 87% among the company’s employees.
- By Daniel Shvartsman Investing.com – Central Banks and earnings will continue to dominate the week ahead.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.